Notice2024-23493
National Institute on Drug Abuse; Notice of Closed Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 10, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 197 (Thursday, October 10, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 197 (Thursday, October 10, 2024)]
[Notices]
[Page 82248]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-23493]
[[Page 82248]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Board of Scientific
Counselors, National Institute on Drug Abuse. The meeting will be
closed to the public as indicated below in accordance with the
provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and evaluation of individual intramural
programs and projects conducted by the National Institute on Drug
Abuse, including consideration of personnel qualifications and
performance, and the competence of individual investigators, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Board of Scientific Counselors, National
Institute on Drug Abuse.
Date: October 22, 2024.
Time: 10:00 a.m. to 4:45 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Place: National Institute on Drug Abuse, NIH, Biomedical
Research Center, 251 Bayview Boulevard, Baltimore, MD 21224.
Meeting Format: Virtual Meeting.
Contact Person: Megan E. Bollinger, M.S., Management Analyst,
Office of the Scientific Director, National Institute on Drug Abuse,
251 Bayview Boulevard, Suite 200, Baltimore, MD 21224, (443) 740-
2466, <a href="/cdn-cgi/l/email-protection#55183032343b7b173a39393c3b323027153b3c3d7b323a23"><span class="__cf_email__" data-cfemail="4c01292b2d22620e23202025222b293e0c222524622b233a">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction Research Programs, National
Institutes of Health, HHS)
Dated: October 7, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-23493 Filed 10-9-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 10, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.